Skip to main content

Table 2 Correlation of MG-H1 with follicular development, fertilization, embryonic development, and implantation in Hishi and control groups a

From: Trapa bispinosa Roxb. extract lowers advanced glycation end-products and increases live births in older patients with assisted reproductive technology: a randomized controlled trial

 

Hishi group

Control group

 

r (n)

p-value

r (n)

p-value

MG-H1 concentration in follicular fluid …

 vs. number of follicles ≧12 mm on hCG day

-0.38 (30)

<0.05

-0.24 (29)

0.20

 vs. number of oocytes retrieved

-0.46 (30)

<0.05

-0.22 (29)

0.26

 vs. number of oocytes fertilized

-0.47 (30)

<0.01

-0.16 (29)

0.42

 vs. number of day-2 embryos

-0.41 (30)

<0.05

-0.01 (29)

0.95

% increase of serum MG-H1 from pre-trial value

 vs. % day-2 embryos per retrieved oocyte

-0.45 (29)

<0.05

-0.21 (30)

0.26

Pre-trial serum MG-H1 concentration …

 vs. % superior day-2 embryos per day-2 embryo

0.37 (30)

<0.05

-0.01 (30)

0.97

 vs. endometrial thickness

0.11 (29)

0.56

-0.51 (30)

<0.01

  1. a Correlations between % increase of serum MG-H1 and % day-2 embryos per retrieved oocyte, and between pre-trial serum MG-H1 and endometrial thickness in the Hishi group, were analyzed by the Pearson test; all other correlations were analyzed by the Spearman test